Mouwasat Medical Services Company (TADAWUL:4002)
Saudi Arabia · Delayed Price · Currency is SAR 70.00
+1.75 (2.56%)
At close: Feb 11, 2026
TADAWUL:4002 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 3,094 | 2,879 | 2,706 | 2,334 | 2,144 | 2,045 | |
Revenue Growth (YoY) | 6.79% | 6.43% | 15.91% | 8.86% | 4.85% | 10.11% |
Cost of Revenue | 1,771 | 1,613 | 1,411 | 1,249 | 1,163 | 1,096 |
Gross Profit | 1,323 | 1,267 | 1,295 | 1,085 | 981.46 | 948.58 |
Selling, General & Admin | 525.96 | 472.05 | 429.25 | 400.78 | 359.53 | 370.75 |
Other Operating Expenses | -7.61 | -7.51 | -8.38 | -6.73 | - | - |
Operating Expenses | 509.3 | 542.94 | 538.12 | 412.32 | 359.53 | 370.75 |
Operating Income | 813.23 | 723.57 | 756.56 | 672.46 | 621.93 | 577.84 |
Interest Expense | -22.38 | -30.46 | -46.46 | -22.88 | -8.2 | -14.04 |
Interest & Investment Income | 31.3 | 22.19 | 6.48 | 0.58 | 0.32 | 1.4 |
Earnings From Equity Investments | -1.28 | - | 10.21 | 9.88 | 10.45 | 4.16 |
Other Non Operating Income (Expenses) | - | - | - | - | 7.71 | 7.12 |
EBT Excluding Unusual Items | 820.87 | 715.3 | 726.79 | 660.03 | 632.21 | 576.47 |
Gain (Loss) on Sale of Investments | -10.69 | -10.69 | - | - | - | - |
Gain (Loss) on Sale of Assets | 1.18 | 1.18 | 0.29 | 0.24 | -0.02 | 0.4 |
Pretax Income | 811.37 | 705.8 | 727.09 | 660.27 | 632.2 | 576.87 |
Income Tax Expense | 25.08 | 36.19 | 38.7 | 27.58 | 21.73 | 15.24 |
Earnings From Continuing Operations | 786.29 | 669.61 | 688.39 | 632.69 | 610.46 | 561.63 |
Minority Interest in Earnings | -30.78 | -23.85 | -30.7 | -33.38 | -32.3 | -33.47 |
Net Income | 755.51 | 645.76 | 657.69 | 599.31 | 578.16 | 528.16 |
Net Income to Common | 755.51 | 645.76 | 657.69 | 599.31 | 578.16 | 528.16 |
Net Income Growth | 14.80% | -1.81% | 9.74% | 3.66% | 9.47% | 25.44% |
Shares Outstanding (Basic) | 200 | 200 | 200 | 200 | 200 | 200 |
Shares Outstanding (Diluted) | 200 | 200 | 200 | 200 | 200 | 200 |
EPS (Basic) | 3.78 | 3.23 | 3.29 | 3.00 | 2.89 | 2.64 |
EPS (Diluted) | 3.78 | 3.23 | 3.29 | 3.00 | 2.89 | 2.64 |
EPS Growth | 14.80% | -1.81% | 9.74% | 3.66% | 9.47% | 25.44% |
Free Cash Flow | 719.47 | 827.41 | 536.75 | 414.52 | 355.9 | 250.81 |
Free Cash Flow Per Share | 3.60 | 4.14 | 2.68 | 2.07 | 1.78 | 1.25 |
Dividend Per Share | 3.000 | 2.000 | 1.750 | 1.500 | 1.375 | 1.250 |
Dividend Growth | 71.43% | 14.29% | 16.67% | 9.09% | 10.00% | 25.00% |
Gross Margin | 42.75% | 43.99% | 47.85% | 46.48% | 45.77% | 46.38% |
Operating Margin | 26.29% | 25.13% | 27.96% | 28.81% | 29.01% | 28.26% |
Profit Margin | 24.42% | 22.43% | 24.31% | 25.68% | 26.96% | 25.83% |
Free Cash Flow Margin | 23.26% | 28.74% | 19.84% | 17.76% | 16.60% | 12.26% |
EBITDA | 1,053 | 955.56 | 974.55 | 855.25 | 773.9 | 720.79 |
EBITDA Margin | 34.04% | 33.19% | 36.02% | 36.64% | 36.09% | 35.25% |
D&A For EBITDA | 239.71 | 231.99 | 217.99 | 182.79 | 151.97 | 142.96 |
EBIT | 813.23 | 723.57 | 756.56 | 672.46 | 621.93 | 577.84 |
EBIT Margin | 26.29% | 25.13% | 27.96% | 28.81% | 29.01% | 28.26% |
Effective Tax Rate | 3.09% | 5.13% | 5.32% | 4.18% | 3.44% | 2.64% |
Revenue as Reported | 3,094 | 2,879 | 2,706 | 2,334 | 2,144 | 2,045 |
Advertising Expenses | - | 31.57 | 35.17 | 28.26 | 26.82 | 28.15 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.